Yalan Wang
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Oncology top 10%
- PARP inhibition in cancer therapy
Papers in
- Oncology 34
- PARP inhibition in cancer therapy 26
- Co-authors
- Yi Tang (20 shared papers)Andrew George Turner (1 shared paper)Fei‐Fei Jin (1 shared paper)Ming Xiao (19 shared papers)Wenjun Zhang (1 shared paper)Malte Fabian Stuecker (1 shared paper)Shan Li Liang (1 shared paper)Qu‐Quan Wang (1 shared paper)
- Journals
- International Journal of Molecular Medicine (4 papers)Scientific Reports (4 papers)Oncology Reports (3 papers)Biosafety and Health (3 papers)Pathology & Oncology Research (3 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Yalan Wang
103 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 137
- Hepatology 262
- Oncology 250
- Physiology 42
- Renewable Energy, Sustainability and the Environment 134
- Epidemiology 239
Countries citing papers authored by Yalan Wang
This map shows the geographic impact of Yalan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yalan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yalan Wang more than expected).
Fields of papers citing papers by Yalan Wang
This network shows the impact of papers produced by Yalan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yalan Wang. The network helps show where Yalan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yalan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 277 | |
| 2 | 2011 | 174 | |
| 3 | 2015 | 128 | |
| 4 | 2019 | 101 | |
| 5 | 2019 | 60 | |
| 6 | 2010 | 41 | |
| 7 | 2023 | 39 | |
| 8 | 2020 | 31 | |
| 9 | 2023 | 29 | |
| 10 | 2019 | 29 | |
| 11 | 2013 | 27 | |
| 12 | 2019 | 27 | |
| 13 | 2018 | 26 | |
| 14 | 2023 | 25 | |
| 15 | 2013 | 24 | |
| 16 | 2016 | 24 | |
| 17 | 2021 | 24 | |
| 18 | 2016 | 23 | |
| 19 | 2009 | 23 | |
| 20 | 2022 | 22 |
About Yalan Wang
Yalan Wang is a scholar working on Oncology, Cancer Research, Molecular Biology, Immunology and Epidemiology, having authored 117 papers that have together received 1.7k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (26 papers), Toxin Mechanisms and Immunotoxins (10 papers), Ophthalmology and Visual Impairment Studies (7 papers), Epigenetics and DNA Methylation (7 papers), RNA modifications and cancer (6 papers), Ferroptosis and cancer prognosis (6 papers), Cell death mechanisms and regulation (5 papers) and Ubiquitin and proteasome pathways (4 papers). The work is most often cited by research in Hepatology (262 citations), Oncology (250 citations), Physiology (42 citations), Renewable Energy, Sustainability and the Environment (134 citations) and Epidemiology (239 citations). Yalan Wang has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Yi Tang, Andrew George Turner, Fei‐Fei Jin, Ming Xiao, Wenjun Zhang, Malte Fabian Stuecker, Shan Li Liang, Qu‐Quan Wang, Xiao‐Niu Peng and Xue‐Feng Yu. Their work appears in journals such as International Journal of Molecular Medicine, Scientific Reports, Oncology Reports, Biosafety and Health and Pathology & Oncology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.